4//SEC Filing
PYSZCZYMUKA GREG 4
Accession 0000912282-23-000399
CIK 0001385818other
Filed
Oct 2, 8:00 PM ET
Accepted
Oct 3, 4:37 PM ET
Size
7.1 KB
Accession
0000912282-23-000399
Insider Transaction Report
Form 4
PYSZCZYMUKA GREG
Chief Commercial Officer
Transactions
- Exercise/Conversion
Common Shares
2023-09-30+208→ 22,351 total - Exercise/Conversion
Restricted Stock Units
2023-09-30−208→ 1,251 total→ Common Shares (208 underlying)
Footnotes (1)
- [F1]Represents restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs were granted on March 31, 2022, and vest as follows: One-third on March 31, 2023; 1/12th of the original grant quarterly thereafter through March 31, 2025. Settlement of vested RSUs will occur as soon as practicable following vesting.
Documents
Issuer
AYTU BIOPHARMA, INC
CIK 0001385818
Entity typeother
Related Parties
1- filerCIK 0001952920
Filing Metadata
- Form type
- 4
- Filed
- Oct 2, 8:00 PM ET
- Accepted
- Oct 3, 4:37 PM ET
- Size
- 7.1 KB